Open Requests for Proposals (RFPs)

Reply to open RFP: Investment in AI Driven Digital Therapeutics

Share

Cancel

1. Basic information

Investment consultant
Oct 26, 2020
Investment in AI Driven Digital Therapeutics
USD1-4mn
Oct 30, 2020
Nov 06, 2020
Nov 06, 2020

2. Investment criteria

Equity

Legal requirements

Fees and costs

0%
0%
0%
0%
0%
0%
Both possible

Track record

$30bn
The prospect has developed and rolled out an AI-augmented digital chronic disease management program that delivers quantifiable health outcomes helping healthcare payors save on avoidable healthcare costs. They have traction from blue chip clients i.e. corporate employers, insurers, pharmaceuticals, and healthcare providers. They currently seek growth capital to tap into the US100bn revenue opportunity across Asia that is growing at 20% CAGR. The following basic information on the abovementioned prospect: • Date of Inception – 2017 • Experienced management team with the CEO having taken another company to USD 1bn IPO • Completed early stage funding from venture capital and pharmaceuticals – USD3mn • Current fund-raising round for expansion – USD4mn
n/a
gross of fees

3. Questionnaire



Cover letter

(0 characters out of 2,000)